Eli Price To Sales Ratio from 2010 to 2025
| LLY Stock | USD 826.76 25.59 3.00% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 15.38316611 | Current Value 16.15 | Quarterly Volatility 5.03426717 |
Check Eli Lilly financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eli Lilly's main balance sheet or income statement drivers, such as Depreciation And Amortization of 966.6 M, Interest Expense of 635.7 M or Total Revenue of 47.3 B, as well as many indicators such as Price To Sales Ratio of 16.15, Dividend Yield of 0.0064 or PTB Ratio of 50.8. Eli financial statements analysis is a perfect complement when working with Eli Lilly Valuation or Volatility modules.
Eli | Price To Sales Ratio |
Latest Eli Lilly's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Eli Lilly and over the last few years. Price to Sales Ratio is figured by comparing Eli Lilly stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Eli Lilly sales, a figure that is much harder to manipulate than other Eli Lilly and multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Eli Lilly's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eli Lilly's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 16.99 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Eli Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 6.84 | |
| Geometric Mean | 5.36 | |
| Coefficient Of Variation | 73.61 | |
| Mean Deviation | 4.14 | |
| Median | 5.48 | |
| Standard Deviation | 5.03 | |
| Sample Variance | 25.34 | |
| Range | 14.2438 | |
| R-Value | 0.92 | |
| Mean Square Error | 4.37 | |
| R-Squared | 0.84 | |
| Slope | 0.97 | |
| Total Sum of Squares | 380.16 |
Eli Price To Sales Ratio History
About Eli Lilly Financial Statements
Eli Lilly investors use historical fundamental indicators, such as Eli Lilly's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Eli Lilly. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 15.38 | 16.15 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Eli Stock Analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.